Figures & data
Figure 2 Orally delivery or injection of NPs to the inflamed intestinal epithelium with impaired epithelial cells and permeable blood vessel.
![Figure 2 Orally delivery or injection of NPs to the inflamed intestinal epithelium with impaired epithelial cells and permeable blood vessel.](/cms/asset/3216b344-fe46-430e-b4c7-9be56f6f602a/dijn_a_12190997_f0002_c.jpg)
Table 1 US Food And Drug Administration Approved Multi-Responsive Oral Drug Delivery Systems For IBD Treatment
Figure 3 Structures of plant-derived nanoparticles (PDNPs), exosome, and synthetic nanoparticles (artificial liposomes). (A) Major forms of PDNPs, (B) mammalian exosome, and (C) major forms of the artificial liposomes. Reprinted with permission from The Royal Society of Chemistry. Yang C, Zhang M, Merlin D. Advances in plant-derived edible nanoparticle-based lipid nano-drug delivery systems as therapeutic nanomedicines. J Mater Chem B. 2018;6(9):1312–1321.Citation40
![Figure 3 Structures of plant-derived nanoparticles (PDNPs), exosome, and synthetic nanoparticles (artificial liposomes). (A) Major forms of PDNPs, (B) mammalian exosome, and (C) major forms of the artificial liposomes. Reprinted with permission from The Royal Society of Chemistry. Yang C, Zhang M, Merlin D. Advances in plant-derived edible nanoparticle-based lipid nano-drug delivery systems as therapeutic nanomedicines. J Mater Chem B. 2018;6(9):1312–1321.Citation40](/cms/asset/47d265db-b7ad-483a-83e8-0f757df1e2d3/dijn_a_12190997_f0003_c.jpg)